Emily Lynde Baumrin, MD, MSCE
she/her
Dermatology
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
Penn Medicine Provider

About me

  • Director, Graft-versus-host Disease Subspecialty Clinic, Department of Dermatology
  • Assistant Professor of Dermatology at the Hospital of the University of Pennsylvania
  • Assistant Professor of Dermatology in Medicine (Hematology-Oncology)

Dr. Emily Baumrin is a dermatologist and internal medicine physician who treats patients with dermatologic diseases. Her research aims to improve the lives of patients suffering from dermatologic complications of transplantation and cancer therapies, including graft-versus-host disease (GVHD). She leads a research program that focuses on understanding skin GVHD, and the best ways to prevent, diagnose and treat this condition. She serves as director of Penn Dermatology’s Graft-versus-host Disease Multi-disciplinary Clinic. 

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Massachusetts General Hospital/Brigham and Women’s Hospital

What my patients think about me

Average Rating

244 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

November 2025
detail oriented
November 2025
great doctor
October 2025
she was good
October 2025
over all very professional

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Baumrin is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Lazarow H, Carulli A, McWilliams T, Kucharczuk C, Hollander L, Catania C, Munshi P, Gabriel P, Loren A, Porter D, Baumrin E Vitamin C deficiency in allogeneic hematopoietic cell transplantation recipients in the peri-transplant period , Support Care Cancer, 33: 2025,755


Baumrin E, Pidala J, Mitchell S, Onstad L, Lee S Development of the Lee Symptom Scale-Skin Sclerosis for chronic GVHD-associated sclerosis , Blood, 145(12): 2025,1321-332


Baumrin E, Cronholm P, Kearney M, Mengesha M, Cesar L, Keddem S, Schapira M, Lee S, Loren A, Gelfand J Outcomes of Importance to Patients Living With Cutaneous Chronic Graft-vs-Host Disease , JAMA Dermatol, 161(3): 2025,281-90


Alvarado SM, Cohen OG, Lattanzio K, Haun P, Gelfand JM, Loren AW, Chung J, Baumrin E Histopathologic Analysis of Chronic Cutaneous Graft-Versus-Host Disease , Am J Dermatopathol, 46(11): 2024,755-60


Pidala J, Onstad L, Baumrin E, Carpenter P, Cutler C, Arai S, Kitko C, Chen G, Lee S Comparison of treatment response measures in cutaneous sclerosis after allogeneic hematopoietic cell transplantation , Blood Adv, 8(17): 2024,4651-657


Choe J, Shields A, Ferreira A, Gold S, Gotschall J, Kamal K, Rios A, Wang R, Baumrin E, Dommasch E, Yeung H, Lipoff J, Barbieri J Isotretinoin for Acne in Transgender and Gender-Diverse Individuals Receiving Masculinizing Hormone Therapy , JAMA Dermatol, 160(7): 2024,741-45


Baumrin E, Shin D, Mitra N, Pidala J, Jurdi N, Lee S, Loren A, Gelfand J Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease , JAMA Dermatol, 160(4): 2024,393-401


Rastogi S, Kim E, Gelfand J, Loren A, Baumrin E Chronic Graft-versus-Host Disease-Associated Muscle Cramps: Severity and Response to Immunomodulatory Therapies , Transplant Cell Ther, 30(3): 2024,338


Mital R, Otto T, Savu A, Baumrin E, Cardones A, Carlesimo M, Caro G, Freites-Martinez A, Hirner J, Markova A, McLellan B, Rossi A, Sauder M, Seminario-Vidal L, Sibaud V, Owen D, Dulmage B, Chen S, Kaffenberger B Detection of novel therapies using a multi-national, multi-institutional registry of cutaneous immune-related adverse events and management , Int J Dermatol, 62(8): 2023,1020-25


Baumrin E, Baker LX, Byrne M, Martin PJ, Flowers ME, Onstad L, Jurdi NE, Chen H, Beeghly-Fadiel A, Lee SJ, Tkaczyk ER Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease , JAMA Dermatol, 159(4): 2023,393-402


View all publications